Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - exemestane, quantity: 25 mg - tablet, sugar coated - excipient ingredients: silicon dioxide; crospovidone; hypromellose; magnesium carbonate hydrate; mannitol; microcrystalline cellulose; methyl hydroxybenzoate; macrogol 6000; polysorbate 80; polyvinyl alcohol; sodium starch glycollate; sucrose; titanium dioxide; cetyl esters wax; purified talc; carnauba wax; shellac; iron oxide black; magnesium stearate; purified water; sorbic acid; dimeticone 100; dimeticonol; benzoic acid - aromasin is indicated for the sequential adjuvant treatment of estrogen receptor-positive early breast cancer in post-menopausal women who have received prior adjuvant tamoxifen therapy.,aromasin is indicated for the treatment of estrogen receptor-positive advanced breast cancer in women with natural or induced postmenopausal status whose disease has progressed following anti-estrogen therapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

alchemy health limited - exemestane 25mg - film coated tablet - 25 mg - active: exemestane 25mg excipient: colloidal silicon dioxide crospovidone hypromellose   macrogol 400 macrogol 6000 magnesium stearate mannitol microcrystalline cellulose polysorbate 80 purified talc sodium starch glycolate titanium dioxide - exemestane is indicated for: · the adjuvant treatment of postmenopausal women with oestrogen receptor positive or receptor unknown early breast cancer after initial adjuvant tamoxifen to reduce the risk of recurrence (distant and loco-regional) and contralateral breast cancer · the treatment of advanced breast cancer in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy · the third-line hormonal treatment of advanced breast cancer in women with natural or induced postmenopausal status whose disease progressed following treatment with anti-oestrogens and either non-steroidal aromatase inhibitors or progestins.

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

nippon kayaku - exemestane - white to slightly grayish white tablet, diameter: 6.2 mm, thickness: 3.9 mm

Ireland - English - HPRA (Health Products Regulatory Authority)

helm pharmaceuticals gmbh - exemestane - coated tablets - 25 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - exemestane - coated tablets - 25 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - exemestane - coated tablet - 25 milligram(s) - aromatase inhibitors; exemestane

Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - exemestane - coated tablet - 25 milligram(s) - aromatase inhibitors; exemestane

Malta - English - Medicines Authority

remedica limited limassol industrial estate, aharnon street, 3056 limassol, cyprus - exemestane - film-coated tablet - exemestane 25 mg - endocrine therapy

Ireland - English - HPRA (Health Products Regulatory Authority)

originalis b.v. - exemestane - coated tablet - 25 milligram(s) - exemestane

Singapore - English - HSA (Health Sciences Authority)

lotus international pte. ltd. - exemestane (micronised) - tablet, film coated - 25.00 mg - exemestane (micronised) 25.00 mg